Arthritis of the knee may be the first symptom of a type of lung cancer that is hard to treat in heavy smokers
Ads by Google
ONCONASE significantly enhances the effect of the radiation response in human non-small cell lung cancer (NSCLC) in vitro and in vivo.
Poniard Pharmaceuticals will present updated results from its Phase 2 trial of picoplatin for lung cancer treatment.
Study results may change medical practice on lung cancer treatment in USA and Europe.
U.S. Senate unanimously reconfirmed its commitment to making lung cancer research a national public health priority.
Scientists have found that a particular gene can block key steps of the lung cancer process in mice.
Scientists have added to the list another powerful tumor suppressor, a gene called LKB1. Their research indicates that this gene is mutated in almost a quarter of all human lung cancers.
Lung cancer patients may not need to wait till their radiation treatment is over to know if it worked.
FDA approved Johnson & Johnson subsidiary Veridex's test called GeneSearch Breast Lymph Node Assay.
Peregrine Pharmaceuticals to conduct Phase II trial of bavituximab in combination with chemotherapy in patients with non-small cell lung cancer.
GlaxoSmithKline's new drug application for ORAL HYCAMTIN capsules, a treatment for relapsed small cell lung cancer, has been granted Priority Review by the United States Food and Drug Administration.
Any number of things can go wrong in the cells of the body to cause cancer -- and clinicians can't tell by just looking at a tumor what exactly triggered the once normal cells to turn cancerous.
New tests developed by researchers at Duke University can determine the precise patterns among thousands of genes to identify the cascade of events, or pathway, that led to the cancer.
Final results from an open-label multi-center Phase 2 clinical trial indicated that Xcytrin Injection may improve the efficacy of stereotactic radiosurgery.
Picoplatin results confirm data analysis from the Company's Phase 2 clinical trial, which demonstrated a survival benefit in patients with recurrent small cell lung cancer (SCLC).
OncoGenex Technologies and Isis Pharmaceuticals announced encouraging preliminary data from a Phase I/II clinical trial of OGX-011 in first-line combination therapy for advanced non-small cell lung cancer.
Pfizer says clinical trials examining its different cancer-fighting approaches showed activity in patients with non-small cell lung cancer (NSCLC).
Genentech today announced that a Roche-sponsored, randomized placebo controlled Phase III clinical study (AVAiL) demonstrated that Avastin (bevacizumab), studied at two different doses in combination with gemcitabine and cisplatin chemotherapy, significantly increased the time patients with advanced non-small cell lung cancer (NSCLC) lived without their disease advancing, as defined by progression-free survival (PFS).
Only First-line Treatment of Lung Cancer with Avastin to Demonstrate Extended Survival in Over a Decade.
Lung cancer is the leading cause of cancer death in African-Americans, with 21,550 new cases expected to be diagnosed and 16,700 deaths expected this year.
Clinicians at Edward Hospital here are using Trilogy technology from Varian Medical Systems to offer some cancer patients a novel treatment that adapts to changes in the tumor so that more healthy tissue can be preserved.
Poniard Pharmaceuticals announced that data from a Phase 2 trial of picoplatin in patients with small cell lung cancer will be presented in a poster session at the 43rd Annual Meeting of the American Society of Clinical Oncology.
The Company is seeking approval to market the drug for the treatment of non-small cell lung cancer patients with brain metastases
Patients who undergo a minimally invasive lung cancer surgery called thoracoscopic lobectomy may derive more benefit from the chemotherapy that follows
Rapamycin, an FDA-approved drug was highly effective in preventing the development of tobacco-related lung tumors in mice.
Lung cancer is one of the only common cancers without a standardized method for early detection and prevention.
A minimally invasive procedure known as radiofrequency ablation is effective for lung cancer treatment in patients who are not candidates for surgery.
Lung cancer patients who lack a particular protein may do more poorly after surgery than those with normal levels of that same protein.
Oncologists should take more advantage of laboratory tests that have the potential to help determine a lung cancer patient's resistance to chemotherapy drugs.
Just a few days after lung cancer surgery, Louise Dellert was thrilled and surprised to be up doing dishes and setting the table.
A hormone that is important in the control of blood pressure also treats lung cancer tumors in mice.